lamotrigine

NDC product · U.S. Food and Drug Administration (openFDA) · United States

  • Product NDC 69117-0045
  • Package NDC 69117-0045-1
  • Package NDC 69117-0045-2
  • Package NDC 69117-0045-3
  • Application number ANDA213949
  • SPL ID 47239426-3d75-73d8-e063-6294a90a608d
  • SPL set ID f7de11a5-5357-4753-b1ac-b15123b50028
  • UNII U3H27498KS
  • RxCUI 850087
  • RxCUI 850091
  • RxCUI 900156
  • RxCUI 900164
  • RxCUI 1098608
  • RxCUI 1146690

What the source publishes

Labeler
Yiling Pharmaceutical, Inc.
Active ingredients
lamotrigine extended-release
Form
TABLET, FILM COATED, EXTENDED RELEASE
Routes
ORAL
Administrative status
present-in-source-snapshot
Marketing status
ANDA
Product type
HUMAN PRESCRIPTION DRUG
Prescription
Prescription or restricted

Names this record is found by

Complete source data
us:fda:ndc:69117-0045_47239426-3d75-73d8-e063-6294a90a608d
{
  "name": "lamotrigine",
  "splId": "47239426-3d75-73d8-e063-6294a90a608d",
  "labels": [
    {
      "setId": "f7de11a5-5357-4753-b1ac-b15123b50028",
      "labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f7de11a5-5357-4753-b1ac-b15123b50028",
      "labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=f7de11a5-5357-4753-b1ac-b15123b50028"
    }
  ],
  "routes": [
    "ORAL"
  ],
  "labeler": "Yiling Pharmaceutical, Inc.",
  "finished": true,
  "packaging": [
    {
      "sample": false,
      "description": "30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (69117-0045-1)",
      "package_ndc": "69117-0045-1",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20211209"
    },
    {
      "sample": false,
      "description": "100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (69117-0045-2)",
      "package_ndc": "69117-0045-2",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20211209"
    },
    {
      "sample": false,
      "description": "500 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (69117-0045-3)",
      "package_ndc": "69117-0045-3",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20211209"
    }
  ],
  "productId": "69117-0045_47239426-3d75-73d8-e063-6294a90a608d",
  "useDomain": "unknown",
  "dosageForm": "TABLET, FILM COATED, EXTENDED RELEASE",
  "productNdc": "69117-0045",
  "deaSchedule": null,
  "genericName": "lamotrigine extended-release",
  "productType": "HUMAN PRESCRIPTION DRUG",
  "listingStatus": "present-in-source-snapshot",
  "targetSpecies": [],
  "approvalStatus": "not-established-by-ndc-listing",
  "labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
  "marketingEndDate": null,
  "activeIngredients": [
    {
      "name": "LAMOTRIGINE",
      "strength": "50 mg/1"
    }
  ],
  "applicationNumber": "ANDA213949",
  "marketingCategory": "ANDA",
  "stateRestrictions": {
    "status": "not-collected",
    "observations": []
  },
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "us.fda.ndc"
  },
  "marketingStartDate": "20211209",
  "targetSpeciesStatus": "not-reported",
  "prescriptionCategory": "prescription-or-restricted",
  "harmonizedIdentifiers": {
    "nui": [
      "N0000175753",
      "N0000008486",
      "N0000175751",
      "N0000187061",
      "N0000000191"
    ],
    "upc": [
      "0369117004920",
      "0369117004739",
      "0369117004517",
      "0369117004913",
      "0369117004425",
      "0369117004722",
      "0369117004838",
      "0369117004418",
      "0369117004616",
      "0369117004623",
      "0369117004715",
      "0369117004432",
      "0369117004524",
      "0369117004814",
      "0369117004821",
      "0369117004630",
      "0369117004937",
      "0369117004531"
    ],
    "unii": [
      "U3H27498KS"
    ],
    "rxcui": [
      "850087",
      "850091",
      "900156",
      "900164",
      "1098608",
      "1146690"
    ],
    "spl_set_id": [
      "f7de11a5-5357-4753-b1ac-b15123b50028"
    ],
    "pharm_class_pe": [
      "Decreased Central Nervous System Disorganized Electrical Activity [PE]"
    ],
    "pharm_class_epc": [
      "Anti-epileptic Agent [EPC]",
      "Mood Stabilizer [EPC]"
    ],
    "pharm_class_moa": [
      "Organic Cation Transporter 2 Inhibitors [MoA]",
      "Dihydrofolate Reductase Inhibitors [MoA]"
    ],
    "manufacturer_name": [
      "Yiling Pharmaceutical, Inc."
    ],
    "is_original_packager": [
      true
    ]
  },
  "listingExpirationDate": "20261231"
}

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=us" \
  --data-urlencode "sourceId=us.fda.ndc" \
  --data-urlencode "id=us:fda:ndc:69117-0045_47239426-3d75-73d8-e063-6294a90a608d"